In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
CME Group Inc (NASDAQ: CME) closed the day trading at $261.94 down -2.05% from the previous closing price of $267.43. In other words, the price has decreased by -$2.05 from its previous closing price. On the day, 1.63 million shares were traded. CME stock price reached its highest trading level at $266.04 during the session, while it also had its lowest trading level at $260.58.
Ratios:
For a better understanding of CME, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 44.84 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.98. For the most recent quarter (mrq), Quick Ratio is recorded 1.02 and its Current Ratio is at 1.02. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.13.
On April 08, 2025, Morgan Stanley Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $301. Raymond James Upgraded its Mkt Perform to Outperform on March 10, 2025, while the target price for the stock was maintained at $287.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 26 ’25 when Cutinho Sunil sold 11,896 shares for $271.47 per share. The transaction valued at 3,229,444 led to the insider holds 17,440 shares of the business.
SUNIL CUTINHO bought 11,896 shares of CME for $3,229,452 on Aug 26 ’25. On Aug 18 ’25, another insider, JAMES NEWSOME, who serves as the Director of the company, bought 32,468 shares for $6.16 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CME now has a Market Capitalization of 94397939712 and an Enterprise Value of 96072482816. As of this moment, CME’s Price-to-Earnings (P/E) ratio for their current fiscal year is 25.35, and their Forward P/E ratio for the next fiscal year is 22.59. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 14.65 while its Price-to-Book (P/B) ratio in mrq is 3.40. Its current Enterprise Value per Revenue stands at 14.935 whereas that against EBITDA is 21.129.
Stock Price History:
The Beta on a monthly basis for CME is 0.42, which has changed by 0.19859064 over the last 52 weeks, in comparison to a change of 0.18469036 over the same period for the S&P500. Over the past 52 weeks, CME has reached a high of $290.79, while it has fallen to a 52-week low of $207.23. The 50-Day Moving Average of the stock is -4.79%, while the 200-Day Moving Average is calculated to be 1.28%.
Shares Statistics:
Over the past 3-months, CME traded about 2.25M shares per day on average, while over the past 10 days, CME traded about 2007520 shares per day. A total of 359.65M shares are outstanding, with a floating share count of 358.84M. Insiders hold about 0.43% of the company’s shares, while institutions hold 91.14% stake in the company. Shares short for CME as of 1755216000 were 5080621 with a Short Ratio of 2.25, compared to 1752537600 on 4728942. Therefore, it implies a Short% of Shares Outstanding of 5080621 and a Short% of Float of 1.4099999.
Dividends & Splits
CME’s forward annual dividend rate is 4.74, up from 4.8 a year ago. Against a Trailing Annual Dividend Yield of 0.017948624The stock’s 5-year Average Dividend Yield is 3.45. The current Payout Ratio is 107.52% for CME, which recently paid a dividend on 2025-06-09 with an ex-dividend date of 2025-09-09. Stock splits for the company last occurred on 2012-07-23 when the company split stock in a 5:1 ratio.
Earnings Estimates
The performance of CME Group Inc (CME) in the stock market is under the watchful eye of 15.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is $2.68, with high estimates of $2.87 and low estimates of $2.57.
Analysts are recommending an EPS of between $11.53 and $10.86 for the fiscal current year, implying an average EPS of $11.13. EPS for the following year is $11.61, with 18.0 analysts recommending between $12.14 and $10.96.
Revenue Estimates
11 analysts predict $1.57B in revenue for the current quarter. It ranges from a high estimate of $1.68B to a low estimate of $1.48B. As of the current estimate, CME Group Inc’s year-ago sales were $1.58BFor the next quarter, 11 analysts are estimating revenue of $1.6B. There is a high estimate of $1.7B for the next quarter, whereas the lowest estimate is $1.55B.
A total of 16 analysts have provided revenue estimates for CME’s current fiscal year. The highest revenue estimate was $6.71B, while the lowest revenue estimate was $6.41B, resulting in an average revenue estimate of $6.51B. In the same quarter a year ago, actual revenue was $6.13BBased on 16 analysts’ estimates, the company’s revenue will be $6.81B in the next fiscal year. The high estimate is $7.27B and the low estimate is $6.48B.
